Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infraclavicular Block vs Local Anesthesia in AV Fistula Surgery
NCT06416111Completed
- Sponsor
- Ankara City Hospital
- Start
- Oct 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine in chronic kidney disease (CKD) (2 arms), sponsored by Ankara City Hospital. Primary endpoints: Tissue Oxygen Saturation and Primary Patency of the Arteriovenous Fistula at 1 month. Started Oct 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT06416111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06416111.